These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. TAR DNA-Binding Protein 43 Is Associated with Rate of Memory, Functional and Global Cognitive Decline in the Decade Prior to Death. Buciuc M; Tosakulwong N; Machulda MM; Whitwell JL; Weigand SD; Murray ME; Reichard RR; Parisi JE; Dickson DW; Boeve BF; Knopman DS; Petersen RC; Josephs KA J Alzheimers Dis; 2021; 80(2):683-693. PubMed ID: 33579840 [TBL] [Abstract][Full Text] [Related]
10. Reduced synchrony in alpha oscillations during life predicts post mortem neurofibrillary tangle density in early-onset and atypical Alzheimer's disease. Ranasinghe KG; Petersen C; Kudo K; Mizuiri D; Rankin KP; Rabinovici GD; Gorno-Tempini ML; Seeley WW; Spina S; Miller BL; Vossel K; Grinberg LT; Nagarajan SS Alzheimers Dement; 2021 Dec; 17(12):2009-2019. PubMed ID: 33884753 [TBL] [Abstract][Full Text] [Related]
12. Structural correlates of cognitive deficits in a selected group of patients with Alzheimer's disease. Caramelli P; Robitaille Y; Laroche-Cholette A; Nitrini R; Gauvreau D; Joanette Y; Lecours AR Neuropsychiatry Neuropsychol Behav Neurol; 1998 Oct; 11(4):184-90. PubMed ID: 9845409 [TBL] [Abstract][Full Text] [Related]
13. Subtypes of dementia with Lewy bodies are associated with α-synuclein and tau distribution. Ferman TJ; Aoki N; Boeve BF; Aakre JA; Kantarci K; Graff-Radford J; Parisi JE; Van Gerpen JA; Graff-Radford NR; Uitti RJ; Pedraza O; Murray ME; Wszolek ZK; Reichard RR; Fields JA; Ross OA; Knopman DS; Petersen RC; Dickson DW Neurology; 2020 Jul; 95(2):e155-e165. PubMed ID: 32561678 [TBL] [Abstract][Full Text] [Related]
14. TAR DNA-binding protein 43 and pathological subtype of Alzheimer's disease impact clinical features. Josephs KA; Whitwell JL; Tosakulwong N; Weigand SD; Murray ME; Liesinger AM; Petrucelli L; Senjem ML; Ivnik RJ; Parisi JE; Petersen RC; Dickson DW Ann Neurol; 2015 Nov; 78(5):697-709. PubMed ID: 26224156 [TBL] [Abstract][Full Text] [Related]
15. Cognitive and Pathological Influences of Tau Pathology in Lewy Body Disorders. Coughlin D; Xie SX; Liang M; Williams A; Peterson C; Weintraub D; McMillan CT; Wolk DA; Akhtar RS; Hurtig HI; Branch Coslett H; Hamilton RH; Siderowf AD; Duda JE; Rascovsky K; Lee EB; Lee VM; Grossman M; Trojanowski JQ; Irwin DJ Ann Neurol; 2019 Feb; 85(2):259-271. PubMed ID: 30549331 [TBL] [Abstract][Full Text] [Related]
16. Neurofibrillary pathology in Alzheimer disease with Lewy bodies: two subgroups. Gearing M; Lynn M; Mirra SS Arch Neurol; 1999 Feb; 56(2):203-8. PubMed ID: 10025425 [TBL] [Abstract][Full Text] [Related]
17. Association of Cortical β-Amyloid Protein in the Absence of Insoluble Deposits With Alzheimer Disease. Yu L; Petyuk VA; Tasaki S; Boyle PA; Gaiteri C; Schneider JA; De Jager PL; Bennett DA JAMA Neurol; 2019 Jul; 76(7):818-826. PubMed ID: 31009033 [TBL] [Abstract][Full Text] [Related]
18. Tau aggregation influences cognition and hippocampal atrophy in the absence of beta-amyloid: a clinico-imaging-pathological study of primary age-related tauopathy (PART). Josephs KA; Murray ME; Tosakulwong N; Whitwell JL; Knopman DS; Machulda MM; Weigand SD; Boeve BF; Kantarci K; Petrucelli L; Lowe VJ; Jack CR; Petersen RC; Parisi JE; Dickson DW Acta Neuropathol; 2017 May; 133(5):705-715. PubMed ID: 28160067 [TBL] [Abstract][Full Text] [Related]
19. Impact of APOE genotype on neuropathologic and neurochemical markers of Alzheimer disease. Tiraboschi P; Hansen LA; Masliah E; Alford M; Thal LJ; Corey-Bloom J Neurology; 2004 Jun; 62(11):1977-83. PubMed ID: 15184600 [TBL] [Abstract][Full Text] [Related]
20. The hippocampal sparing subtype of Alzheimer's disease assessed in neuropathology and in vivo tau positron emission tomography: a systematic review. Ferreira D; Mohanty R; Murray ME; Nordberg A; Kantarci K; Westman E Acta Neuropathol Commun; 2022 Nov; 10(1):166. PubMed ID: 36376963 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]